Low bioavailability as a cause of apparent failure of dihydroergotamine in orthostatic hypotension.
- 26 July 1980
- Vol. 281 (6235), 275-276
- https://doi.org/10.1136/bmj.281.6235.275-a
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Treatment of orthostatic hypotension with dihydroergotamine.BMJ, 1979
- The Sympathetic-Nervous-System Defect in Primary Orthostatic HypotensionNew England Journal of Medicine, 1977
- COMPARATIVE PHARMACOKINETIC INVESTIGATIONS WITH TRITIUM-LABELED ERGOT ALKALOIDS AFTER ORAL AND INTRAVENOUS ADMINISTRATION IN MAN1977
- 9,10-Dihydroergotamine: Production of antibodies and radioimmunoassayCellular and Molecular Life Sciences, 1976